VEGF gene polymorphism association with diabetic foot ulcer.

[1]  S. Juo,et al.  Functional vascular endothelial growth factor gene polymorphisms and diabetes: effect on coronary collaterals in patients with significant coronary artery disease. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[2]  Bagher Larijani,et al.  VEGF gene polymorphism association with diabetic neuropathy , 2010, Molecular Biology Reports.

[3]  Li Dong,et al.  Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells , 2009, Molecular Biology Reports.

[4]  R. Kirsner,et al.  Vascular endothelial growth factor delivery via gene therapy for diabetic wounds: first steps. , 2009, The Journal of investigative dermatology.

[5]  O. Stojadinović,et al.  Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. , 2009, Journal of Investigative Dermatology.

[6]  F. Setacci,et al.  Diabetic patients: epidemiology and global impact. , 2009, The Journal of cardiovascular surgery.

[7]  Richard Hellman,et al.  Comprehensive foot examination and risk assessment. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  Michael J. Mueller,et al.  Comprehensive Foot Examination and Risk Assessment , 2008, Diabetes Care.

[9]  A. Boulton,et al.  The diabetic foot: grand overview, epidemiology and pathogenesis , 2008, Diabetes/metabolism research and reviews.

[10]  H. Biri,et al.  No association between polymorphism in the vascular endothelial growth factor gene at position−460 and sporadic prostate cancer in the Turkish population , 2008, Molecular Biology Reports.

[11]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[12]  E. Feldman,et al.  The role of growth factors in diabetic peripheral neuropathy , 2004, Journal of the peripheral nervous system : JPNS.

[13]  M. Bartoli,et al.  Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives , 2003, Diabetes/metabolism research and reviews.

[14]  M. Khamaisi,et al.  The emerging role of VEGF in diabetic kidney disease. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  J. Griffiths,et al.  The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[16]  W. Renner,et al.  A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels , 2000, Journal of Vascular Research.

[17]  L. Aiello,et al.  Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.

[18]  K. Skorecki,et al.  Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. , 2000, Diabetes care.

[19]  M. Bottomley,et al.  Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. , 2000, Cytokine.

[20]  J. Gross,et al.  Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. , 1999, Diabetes.

[21]  Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial , 1997, Diabetes.

[22]  O. B. O. T. I. Group,et al.  Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM , 1997, Diabetologia.

[23]  A. Donker,et al.  Endothelial dysfunction and pathogenesis of diabetic angiopathy. , 1997, Cardiovascular research.

[24]  A. Krolewski,et al.  Familial factors determine the development of diabetic nephropathy in patients with IDDM , 1996, Diabetologia.

[25]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[26]  M B Brown,et al.  A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.

[27]  E. Bauer,et al.  Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.

[28]  H. Parving,et al.  Is diabetic nephropathy an inherited complication? , 1992, Kidney international.

[29]  K. Earle,et al.  Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. , 1992, The New England journal of medicine.

[30]  M. F. Saad,et al.  Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[31]  D. Connolly,et al.  Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. , 1990, Cancer research.

[32]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[33]  Factors in Development of Diabetic Neuropathy: Baseline Analysis of Neuropathy in Feasibility Phase of Diabetes Control and Complications Trial (DCCT) , 1988, Diabetes.

[34]  F. W. Wagner,et al.  The Dysvascular Foot: A System for Diagnosis and Treatment , 1981, Foot & ankle.

[35]  Wagner Fw.  The Dysvascular Foot: A System for Diagnosis and Treatment: , 1981 .

[36]  Gang Wu,et al.  Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population , 2009, Molecular Biology Reports.

[37]  J. Hanft,et al.  Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. , 2008, Journal of wound care.

[38]  Y. Iwamoto,et al.  Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[39]  L. Chouchane,et al.  Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness , 2007, Molecular Biology Reports.

[40]  Jie Li,et al.  Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix , 2003, Microscopy research and technique.

[41]  P. Harden,et al.  Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. , 2002, Journal of the American Society of Nephrology : JASN.